Hickman; Emma
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hickman; Emma.The latest application filed is for "rnai inhibition of alpha-enac expression".
Company Profile
5.22.22
- Hickman; Emma - Horsham GB
- Hickman; Emma - Sutton GB
Patent Activity
| Patent | Date |
|---|---|
| RNAi Inhibition of Alpha-ENaC Expression App 20220235361 - Van Heeke; Gino ; et al. | 2022-07-28 |
| RNAi Inhibition of Alpha-ENaC Expression App 20220112505 - Van Heeke; Gino ; et al. | 2022-04-14 |
| RNAi inhibition of alpha-ENaC expression Grant 11,208,662 - Van Heeke , et al. December 28, 2 | 2021-12-28 |
| RNAi Inhibition of Alpha-ENaC Expression App 20200157550 - Van Heeke; Gino ; et al. | 2020-05-21 |
| Organic compositions to treat beta-ENaC-related diseases Grant 10,550,391 - De Fougerolles , et al. Fe | 2020-02-04 |
| RNAi inhibition of alpha-ENaC expression Grant 10,544,418 - Van Heeke , et al. Ja | 2020-01-28 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20180355362 - De Fougerolles; Antonin ; et al. | 2018-12-13 |
| Organic compositions to treat Beta-ENaC-related diseases Grant 10,081,811 - De Fougerolles , et al. September 25, 2 | 2018-09-25 |
| RNAi Inhibition of Alpha-ENaC Expression App 20180148726 - Van Heeke; Gino ; et al. | 2018-05-31 |
| RNAi inhibition of alpha-ENaC expression Grant 9,914,927 - Van Heeke , et al. March 13, 2 | 2018-03-13 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20170327829 - De Fougerolles; Antonin ; et al. | 2017-11-16 |
| Organic compositions to treat beta-ENaC-related diseases Grant 9,752,152 - De Fougerolles , et al. September 5, 2 | 2017-09-05 |
| RNAi Inhibition of Alpha-ENaC Expression App 20160376599 - Van Heeke; Gino ; et al. | 2016-12-29 |
| RNAi inhibition of alpha-ENaC expression Grant 9,476,052 - Van Heeke , et al. October 25, 2 | 2016-10-25 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20160272979 - De Fougerolles; Antonin ; et al. | 2016-09-22 |
| Organic compositions to treat beta-ENaC-related diseases Grant 9,376,683 - De Fougerolles , et al. June 28, 2 | 2016-06-28 |
| RNAi Inhibition of A1pha-ENaC Expression App 20150284726 - VAN HEEKE; Gino ; et al. | 2015-10-08 |
| Organic Compositions to Treat Beta-ENaC-Related diseases App 20150275218 - DE FOUGEROLLES; Antonin ; et al. | 2015-10-01 |
| Organic compositions to treat Beta-ENaC-related diseases Grant 9,080,175 - De Fougerolles , et al. July 14, 2 | 2015-07-14 |
| RNAi inhibition of alpha-ENaC expression Grant 9,074,212 - Van Heeke , et al. July 7, 2 | 2015-07-07 |
| ORGANIC COMPOSITIONS TO TREAT Beta-ENaC-RELATED DISEASES App 20140107179 - DE FOUGEROLLES; Antonin ; et al. | 2014-04-17 |
| Organic compositions to treat Beta-ENaC-related diseases Grant 8,598,335 - De Fougerolles , et al. December 3, 2 | 2013-12-03 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20130012571 - DE FOUGEROLLES; Antonin ; et al. | 2013-01-10 |
| Organic compositions to treat beta-ENaC-related diseases Grant 8,344,127 - De Fougerolles , et al. January 1, 2 | 2013-01-01 |
| Organic compositions to treat Beta-ENaC-related diseases Grant 8,344,129 - De Fougerolles , et al. January 1, 2 | 2013-01-01 |
| Organic compositions to treat beta-ENaC-related diseases Grant 8,344,131 - De Fougerolles , et al. January 1, 2 | 2013-01-01 |
| Organic compositions to treat Beta-ENaC-related diseases Grant 8,344,130 - De Fougerolles , et al. January 1, 2 | 2013-01-01 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20120122960 - DE FOUGEROLLES; Antonin ; et al. | 2012-05-17 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20120115934 - DE FOUGEROLLES; Antonin ; et al. | 2012-05-10 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20120115933 - DE FOUGEROLLES; Antonin ; et al. | 2012-05-10 |
| RNAi inhibition of alpha-ENaC expression Grant 8,168,606 - Van Heeke , et al. May 1, 2 | 2012-05-01 |
| RNAi inhibition of alpha-ENaC expression Grant 8,119,612 - Van Heeke , et al. February 21, 2 | 2012-02-21 |
| Organic Compositions to Treat Beta-ENaC-Related Diseases App 20110263681 - DE FOUGEROLLES; Antonin ; et al. | 2011-10-27 |
| RNAi inhibition of alpha-ENaC expression Grant 7,943,592 - Van Heeke , et al. May 17, 2 | 2011-05-17 |
| RNAi inhibition of alpha-ENaC expression Grant 7,939,508 - Van Heeke , et al. May 10, 2 | 2011-05-10 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100216971 - VAN HEEKE; Gino ; et al. | 2010-08-26 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100216972 - VAN HEEKE; Gino ; et al. | 2010-08-26 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100210514 - VAN HEEKE; Gino ; et al. | 2010-08-19 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100210513 - VAN HEEKE; Gino ; et al. | 2010-08-19 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100190714 - VAN HEEKE; Gino ; et al. | 2010-07-29 |
| RNAi inhibition of alpha-ENaC expression Grant 7,718,632 - Van Heeke , et al. May 18, 2 | 2010-05-18 |
| RNAi Inhibition of Alpha-ENaC Expression App 20090156529 - VAN HEEKE; Gino ; et al. | 2009-06-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 